成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

2-METHYLCARBAMOYLISONICOTINIC ACID ETHYL ESTER

2-METHYLCARBAMOYLISONICOTINIC ACID ETHYL ESTER Struktur
332013-42-0
CAS-Nr.
332013-42-0
Englisch Name:
2-METHYLCARBAMOYLISONICOTINIC ACID ETHYL ESTER
Synonyma:
ETHYL 2-[(METHYLAMINO)CARBONYL]ISONICOTINATE;2-METHYLCARBAMOYLISONICOTINIC ACID ETHYL ESTER;Ethyl 2-(methylcarbamoyl)pyridine-4-carboxylate;2-[(METHYLAMINO)CARBONYL]-PYRIDINE-4-CARBOXYLIC ACID ETHYL ESTER;4-Pyridinecarboxylic acid, 2-[(methylamino)carbonyl]-, ethyl ester;2-[(Methylamino)carbonyl]-pyridine-4-carboxylic acid ethyl
ester
CBNumber:
CB3352128
Summenformel:
C10H12N2O3
Molgewicht:
208.21
MOL-Datei:
332013-42-0.mol

2-METHYLCARBAMOYLISONICOTINIC ACID ETHYL ESTER Eigenschaften

Siedepunkt:
371.4±27.0 °C(Predicted)
Dichte
1.173±0.06 g/cm3(Predicted)
pka
14.06±0.46(Predicted)

Sicherheit

2-METHYLCARBAMOYLISONICOTINIC ACID ETHYL ESTER Chemische Eigenschaften,Einsatz,Produktion Methoden

2-METHYLCARBAMOYLISONICOTINIC ACID ETHYL ESTER Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Telatinib

2-METHYLCARBAMOYLISONICOTINIC ACID ETHYL ESTER Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Synchem OHG +49 5662 408730
info@synchem.de Germany 4705 70
ChengDu TongChuangYuan Pharmaceutical Co.Ltd 028-83379370 13880556291
 tcy@tcypharm.com China 6270 58
Chengdu Feibai Pharmaceutical Co., Ltd. 028-84641798 18782128315
 3302391190@qq.com China 9219 55
Wuhan Anruike Pharmaceutical Technology Co., Ltd. 18572841024
 28128719@qq.com China 1985 58
  • ETHYL 2-[(METHYLAMINO)CARBONYL]ISONICOTINATE
  • 2-[(Methylamino)carbonyl]-pyridine-4-carboxylic acid ethyl
    ester
  • 2-METHYLCARBAMOYLISONICOTINIC ACID ETHYL ESTER
  • 2-[(METHYLAMINO)CARBONYL]-PYRIDINE-4-CARBOXYLIC ACID ETHYL ESTER
  • 4-Pyridinecarboxylic acid, 2-[(methylamino)carbonyl]-, ethyl ester
  • Ethyl 2-(methylcarbamoyl)pyridine-4-carboxylate
  • 332013-42-0
Copyright 2019 ? ChemicalBook. All rights reserved